cdmo.directory
← Compare landing

ProBioGen AG vs Viralgen

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/probiogen/viralgen

CategoryProBioGen AGViralgen
Listed sitecdmocdmo
SummaryProBioGen is a fully integrated CDMO specializing in development and GMP manufacturing of therapeutic proteins, viral vectors, and vaccines, with proprietary platforms including CHO.RiGHT® for cell line development and AGE1.CR.pIX® for vaccine production.Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.
Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
  • Analytical Method Development & Validation
  • Regulatory Affairs
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
  • AAV / Viral Vector Platform
  • Gene Therapy
Indications
  • Oncology
  • Rare Disease
Locations
  • Headquarters, Berlin, Berlin, Germany
  • Office, Berlin, Berlin, Germany
  • Headquarters & Manufacturing, San Sebastián, Basque Country, Spain
Certifications
  • EMA · Identifier: GMP compliant
  • FDA · Identifier: GMP compliant
  • EMA · Identifier: AEMPS/EMA certified
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.